Crosstalk of vascular 5-HT1 receptors with other receptors: Clinical implications

Neuropharmacology

Volumn 55, Issue 6, 2008, Pages 986-993

  MaassenVanDenBrink, Antoinette ^a   Centurión, David ^b   Villalón, Carlos M ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

5 HT1 receptor; Artery; Contraction; Crosstalk; Nitric oxide; Thromboxane A2

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; HISTAMINE; NORADRENALIN; PHENYLEPHRINE; POTASSIUM CHLORIDE; PROSTAGLANDIN F2 ALPHA; SEROTONIN 1 RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; THROMBOXANE A2;

ARTICLE; CEREBROVASCULAR DISEASE; HUMAN; HYPERTENSION; MOLECULAR INTERACTION; NONHUMAN; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SECOND MESSENGER; VARIANT ANGINA PECTORIS; VASOCONSTRICTION;

AGING; ANIMALS; BLOOD VESSELS; HUMANS; NITRIC OXIDE; RECEPTORS, SEROTONIN; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SEROTONIN AGENTS; VASCULAR DISEASES;

EID: 53749089676     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.06.051     Document Type: Article

References (127)

1. Aalkjaer C., Danielsen H., Johannesen P., Pedersen E.B., Rasmussen A., and Mulvany M.J. Abnormal vascular function and morphology in pre-eclampsia: a study of isolated resistance vessels. Clinical Science (London) 69 (1985) 477-482
2. Anghileri E., Toso V., and Perini F. Acute myocardial infarction after sumatriptan administration for cluster headache. Neurological Sciences 26 (2006) 456-459
3. Angus J.A. 5-HT receptors in the coronary circulation. Trends in Pharmacological Sciences 10 (1989) 89-90
4. Ansar S., and Edvinsson L. Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke 39 (2008) 185-190
5. 1B receptors and cerebral blood flow reduction. Journal of Neurosurgery 106 (2007) 881-886
6. 1 receptor upregulation correlates with reduction in regional CBF after subarachnoid hemorrhage. American Journal of Physiology. Heart and Circulatory Physiology 293 (2007) H3750-H3758
7. Ashton J.H., Benedict C.R., Fitzgerald C., Raheja S., Taylor A., Campbell W.B., Buja L.M., and Willerson J.T. Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation 73 (1986) 572-578
8. 1B receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat. Hypertension 38 (2001) 891-895
9. 1B receptor-mediated contraction of rabbit saphenous vein and basilar artery: role of vascular endothelium. The Journal of Pharmacology and Experimental Therapeutics 309 (2004) 825-832
10. Bolte A.C., van Eyck J., Gaffar S.F., van Geijn H.P., and Dekker G.A. Ketanserin for the treatment of preeclampsia. Journal of Perinatal Medicine 29 (2001) 14-22
11. Bolte A.C., van Geijn H.P., and Dekker G.A. Pathophysiology of preeclampsia and the role of serotonin. European Journal of Obstetrics, Gynecology, and Reproductive Biology 95 (2001) 12-21
12. Bottalico B., Larsson I., Brodszki J., Hernandez-Andrade E., Casslen B., Marsal K., and Hansson S.R. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 25 (2004) 518-529
13. 1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery. British Journal of Pharmacology 129 (2000) 501-508
14. Brum J.M., Sufan Q., Lane G., and Bove A.A. Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs. Circulation 70 (1984) 1066-1073
15. 1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage. Stroke 34 (2003) 1269-1275
16. Chan J.S., Lee J.W., Ho M.K., and Wong Y.H. Preactivation permits subsequent stimulation of phospholipase C by G(i)-coupled receptors. Molecular Pharmacology 57 (2000) 700-708
17. Chesley L.C., Talledo E., Bohler C.S., and Zuspan F.P. Vascular reactivity to angiotensin II and norepinephrine in pregnant women. American Journal of Obstetrics and Gynecology 91 (1965) 837-842
18. Chester A.H., Martin G.R., Bodelsson M., Arneklo-Nobin B., Tadjkarimi S., Törnebrandt K., and Yacoub M.H. 5-Hydroxytriptamine receptor profile in healthy and diseased human epicardial coronary arteries. Cardiovascular Research 24 (1990) 932-937
19. Chester A.H., O'Neil G.S., Allen S.P., Luu T.N., Tadjkarimi S., and Yacoub M.H. Effect of endothelin on normal and diseased human coronary arteries. European Journal of Clinical Investigation 22 (1992) 210-213
20. 1 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation 87 (1993) 874-880
21. 1 and 5-hydroxytryptamine in the radial artery compared to the internal thoracic artery. General Pharmacology 35 (2000) 89-93
22. 1-like receptors revealed by precontraction of rabbit isolated mesenteric artery. British Journal of Pharmacology 114 (1995) 309-314
23. 1-like receptor agonist sumatriptan in anaesthetised rabbits. European Journal of Pharmacology 304 (1996) 87-92
24. Chu A., and Cobb F.R. Vasoactive effects of serotonin on proximal coronary arteries in awake dogs. Circulation Research 61 (1987) II81-II87
25. Cocks T.M., and Angus J.A. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305 (1983) 627-630
26. Cocks T.M., Kemp B.K., Pruneau D., and Angus J.A. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. British Journal of Pharmacology 110 (1993) 360-368
27. Cohen M.L., and Schenck K. 5-Hydroxytryptamine(1F) receptors do not participate in vasoconstriction: lack of vasoconstriction to LY344864, a selective serotonin(1F) receptor agonist in rabbit saphenous vein. The Journal of Pharmacology and Experimental Therapeutics 290 (1999) 935-939
28. Connor H.E., and Feniuk W. Influence of the endothelium on contractile effects of 5-hydroxytryptamine and selective 5-HT agonists in canine basilar artery. British Journal of Pharmacology 96 (1989) 170-178
29. Cutrer F.M., Limmroth V., Waeber C., Yu X., and Moskowitz M.A. New targets for antimigraine drug development. In: Goadsby P.J., and Silberstein S. (Eds). Headache (1997), Butterworth-Heinemann, Philadelphia 59-72
30. 1D (BRL15572) receptor antagonists. European Journal of Pharmacology 362 (1998) 69-72
31. Dodick D.W., Martin V.T., Smith T., and Silberstein S. Cardiovascular tolerability and safety of triptans: a review of clinical data. Headache 44 Suppl. 1 (2004) S20-S30
32. Dong Y.L., Green K.E., Vegiragu S., Hankins G.D., Martin E., Chauhan M., Thota C., and Yallampalli C. Evidence for decreased calcitonin gene-related peptide (CGRP) receptors and compromised responsiveness to CGRP of fetoplacental vessels in preeclamptic pregnancies. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 2336-2343
33. Duley L., and Henderson-Smart D.J. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database of Systematic Reviews (2002) CD001449
34. Erbilen E., Ozhan H., Akdemir R., and Yazici M. A case of myocardial infarction with sumatriptan use. Pediatric Cardiology 26 (2005) 464-466
35. Ferrari M.D., and Saxena P.R. Clinical and experimental effects of sumatriptan in humans. Trends in Pharmacological Sciences 14 (1993) 129-133
36. 1 receptors in migraine pathophysiology and treatment. European Journal of Neurology 2 (1995) 5-21
37. 1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358 (2001) 1668-1675
38. 1B receptor subtype and aging in rat resistance vessels. Pharmacology 81 (2008) 70-78
39. Fulton J.A., Kahn J., Nelson L.S., and Hoffman R.S. Renal infarction during the use of rizatriptan and zolmitriptan: two case reports. Clinical Toxicology (Philadelphia) 44 (2006) 177-180
40. 1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery. British Journal of Pharmacology 127 (1999) 1327-1336
41. 1B receptor in the rabbit carotid artery. British Journal of Pharmacology 131 (2000) 1723-1731
42. 1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience 122 (2003) 491-498
43. Goadsby P.J., Edvinsson L., and Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28 (1990) 183-187
44. 1F) receptor agonist LY334370 for acute migraine: a randomised controlled trial. Lancet 358 (2001) 1230-1234
45. Golino P., and Maseri A. Serotonin receptors in human coronary arteries. Circulation 90 (1994) 1573-1575
46. Golino P., Piscione F., Willerson J.T., Cappelli-Bigazzi M., Focaccio A., Villari B., Indolfi C., Russolillo E., Condorelli M., and Chiariello M. Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. The New England Journal of Medicine 324 (1991) 641-648
47. Golino P., Piscione F., Benedict C.R., Anderson H.V., Cappelli-Bigazzi M., Indolfi C., Condorelli M., Chiariello M., and Willerson J.T. Local effect of serotonin released during coronary angioplasty. The New England Journal of Medicine 330 (1994) 523-528
48. 1D agonist, in patients with acute migraine. Cephalalgia 21 (2001) 727-732
49. Gul H., and Yildiz O. Amplification of sumatriptan-induced contractions with phenylephrine, histamine and KCl in the isolated human mesenteric artery: in-vitro evidence for sumatriptan-induced mesenteric ischaemia. Naunyn-Schmiedeberg's Archives of Pharmacology 366 (2002) 254-261
50. Gupta S., Hanff L.M., Visser W., Steegers E.A., Saxena P.R., Vulto A.G., and MaassenVanDenBrink A. Functional reactivity of 5-HT receptors in human umbilical cord and maternal subcutaneous fat arteries after normotensive or pre-eclamptic pregnancy. Journal of Hypertension 24 (2006) 1345-1353
51. Gupta S., Mehrotra S., Villalón C.M., Garrelds I.M., de Vries R., van Kats J.P., Sharma H.S., Saxena P.R., and MaassenVanDenBrink A. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity. European Journal of Pharmacology 530 (2006) 107-116
52. Hack J.B. Oral sumatriptan-induced myocardial infarction. Journal of Toxicology. Clinical Toxicology 42 (2004) 309-311
53. Hirsh P.D., Hillis L.D., Campbell W.B., Firth B.G., and Willerson J.T. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease. The New England Journal of Medicine 304 (1981) 685-691
54. 1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain Research 998 (2004) 91-99
55. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., and Humphrey P.P.A. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacological Reviews 46 (1994) 157-203
56. 1Dbeta receptor mediates the supersensitivity of isolated coronary artery to serotonin in variant angina. Chest 113 (1998) 243-244
57. 1Dβ receptors. Circulation 90 (1994) 1141-1153
58. Kaumann A.J., and Levy F.O. 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacology & Therapeutics 111 (2006) 674-706
59. Lam J.Y., Chesebro J.H., Steele P.M., Badimon L., and Fuster V. Is vasospasm related to platelet deposition? Relationship in a porcine preparation of arterial injury in vivo. Circulation 75 (1987) 243-248
60. Lesch K.P., and Lerer B. The 5-HT receptor-G-protein-effector system complex in depression. I. Effect of glucocorticoids. Journal of Neural Transmission. General Section 84 (1991) 3-18
61. Liu H.S., Chu T.Y., Yu M.H., Chang Y.K., Ko C.S., and Chao C.F. Thromboxane and prostacyclin in maternal and fetal circulation in pre-eclampsia. International Journal of Gynaecology and Obstetrics 63 (1998) 1-6
62. MaassenVanDenBrink A., and Saxena P.R. Coronary vasoconstrictor potential of triptans: a review of in vitro pharmacologic data. Headache 44 Suppl 1 (2004) S13-S19
63. MaassenVanDenBrink A., Bax W.A., Ferrari M.D., Zijlstra F.J., Bos E., and Saxena P.R. Augmented contraction of the human isolated coronary artery by sumatriptan; a possible role for endogenous thromboxane. British Journal of Pharmacology 119 (1996) 855-862
64. MaassenVanDenBrink A., Reekers M., Bax W.A., Ferrari M.D., and Saxena P.R. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 98 (1998) 25-30
65. 1F receptor gene: no evidence for involvement in response to sumatriptan in migraine patients. American Journal of Medical Genetics 77 (1998) 415-420
66. 1B receptor polymorphism and clinical response to sumatriptan. Headache 38 (1998) 288-291
67. MaassenVanDenBrink A., Bax W.A., Ramrattan N.N., Ferrari M.D., and Saxena P.R. Human isolated coronary artery contraction to sumatriptan: a post hoc analysis. Cephalalgia 19 (1999) 651-654
68. MaassenVanDenBrink A., van den Broek R.W.M., de Vries R., Bogers A.J.C., Avezaat C.J.J., and Saxena P.R. Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology 55 (2000) 1524-1530
69. MacAlpin R.N. Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction. Circulation 61 (1980) 296-301
70. 1-receptor agonist on central haemodynamics and the coronary circulation. British Journal of Clinical Pharmacology 34 (1992) 541-546
71. 1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation 87 (1993) 401-405
72. 1-receptor stimulation in pulmonary arteries from chronic hypoxic rats: role of pharmacological synergy. British Journal of Pharmacology 134 (2001) 614-620
73. MacLennan S.J., Bolofo M.L., and Martin G.R. Amplifying interactions between spasmogens in vascular smooth muscle. Biochemical Society Transactions 21 (1993) 1145-1150
74. Martin G.R., Eglen R.M., Hamblin M.W., Hoyer D., and Yocca F. The structure and signalling properties of 5-HT receptors: an endless diversity?. Trends in Pharmacological Sciences 19 (1998) 2-4
75. 1B/1D receptors. Annals of the New York Academy of Sciences 861 (1998) 251-252
76. 1D receptor agonist PNU-142633. Cephalalgia 22 (2002) 799-806
77. McFadden E.P., Clarke J.G., Davies G.J., Kaski J.C., Haider A.W., and Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. The New England Journal of Medicine 324 (1991) 648-654
78. McFadden E.P., Bauters C., Lablanche J.M., Quandalle P., Leroy F., and Bertrand M.E. Response of human coronary arteries to serotonin after injury by coronary angioplasty. Circulation 88 (1993) 2076-2085
79. 1B receptor gene are not major determinants of the clinical response to sumatriptan. Headache 47 (2007) 711-716
80. Merviel P., Carbillon L., Challier J.C., Rabreau M., Beaufils M., and Uzan S. Pathophysiology of preeclampsia: links with implantation disorders. European Journal of Obstetrics, Gynecology, and Reproductive Biology 115 (2004) 134-147
81. Middelkoop C.M., Dekker G.A., Kraayenbrink A.A., and Popp-Snijders C. Platelet-poor plasma serotonin in normal and preeclamptic pregnancy. Clinical Chemistry 39 (1993) 1675-1678
82. Mullane K.M., Bradley G., and Moncada S. The interactions of platelet-derived mediators on isolated canine coronary arteries. European Journal of Pharmacology 84 (1982) 115-118
83. Nilsson T., Longmore J., Shaw D., Pantev E., Bard J.A., Branchek T., and Edvinsson L. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. European Journal of Pharmacology 372 (1999) 49-56
84. Nishimura Y. Characterization of 5-hydroxytryptamine receptors mediating contractions in basilar arteries from stroke-prone spontaneously hypertensive rats. British Journal of Pharmacology 117 (1996) 1325-1333
85. 1Db receptor gene. Biochemical and Biophysical Research Communications 205 (1994) 1194-1200
86. Pacheco-Coronado R., McMullan P.W., Galbut B.H., Galbut E.J., Snell J., Schaer G.L., and Kavinsky C.J. Myocardial infarction after taking zolmitriptan. The Yale Journal of Biology and Medicine 78 (2005) 147-150
87. Phebus L.A., Johnson K.W., Zgombick J.M., Gilbert P.J., Van Belle K., Mancuso V., Nelson D.L., Calligaro D.O., Kiefer Jr. A.D., Branchek T.A., and Flaugh M.E. Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine. Life Sciences 61 (1997) 2117-2126
88. Plosker G.L., and McTavish D. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 47 (1994) 622-651
89. Price G.W., Burton M.J., Collin L.J., Duckworth M., Gaster L., Gothert M., Jones B.J., Roberts C., Watson J.M., and Middlemiss D.N. SB-216641 and BRL-15572-compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn-Schmiedeberg's Archives of Pharmacology 356 (1997) 312-320
90. 1B receptor in experimental pulmonary hypertension. The European Respiratory Journal 22 (2003) 408-412
91. 1-like receptors: a time to bid goodbye. Trends in Pharmacological Sciences 19 (1998) 311-316
92. Schmitz J.M., Apprill P.G., Buja L.M., Willerson J.T., and Campbell W.B. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Circulation Research 57 (1985) 223-231
93. Selbie L.A., and Hill S.J. G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. Trends in Pharmacological Sciences 19 (1998) 87-93
94. 1F receptor agonist LY334370. Cephalalgia 19 (1999) 851-858
95. 1B receptor. International Journal of Cardiology 114 (2007) 188-194
96. Steyn D.W., and Odendaal H.J. Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin. Obstetrical & Gynecological Survey 55 (2000) 582-589
97. Sweeney G., Templeton A., Clayton R.A., Baird M., Sheridan S., Johnston E.D., and MacLean M.R. Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: relationship to tone and cyclic nucleotide levels. Journal of Cardiovascular Pharmacology 26 (1995) 751-760
98. Tfelt-Hansen P., De Vries P., and Saxena P.R. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60 (2000) 1259-1287
99. 1D receptor agonists in the rabbit isolated saphenous vein. British Journal of Pharmacology 119 (1996) 35-42
100. van den Berg E.K., Schmitz J.M., Benedict C.R., Malloy C.R., Willerson J.T., and Dehmer G.J. Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology. Circulation 79 (1989) 116-124
101. 1D receptor antagonists and in situ hybridization. Cephalalgia 22 (2002) 83-93
102. Vanhoutte P.M. Vascular effects of serotonin and ischemia. Journal of Cardiovascular Pharmacology 16 (1990) S15-S19
103. Vanhoutte P.M., and Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 80 (1989) 1-9
104. 1A receptors involved?. European Journal of Pharmacology 201 (1991) 17-27
105. Verheggen R., Hundeshagen A.G., Brown A.M., Schindler M., and Kaumann A.J. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. British Journal of Pharmacology 124 (1998) 1345-1354
106. 1B receptors to the total contractile amplitude in arteries from Phe124Cys heterozygous individuals. Pharmacogenetics and Genomics 16 (2006) 601-607
107. Vikman P., and Edvinsson L. Gene expression profiling in the human middle cerebral artery after cerebral ischemia. European Journal of Neurology 13 (2006) 1324-1332
108. Villalón C.M., and Centurión D. Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications. Naunyn-Schmiedeberg's Archives of Pharmacology 376 (2007) 45-63
109. Villalón C.M., Centurión D., Valdivia L.F., De Vries P., and Saxena P.R. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proceedings of the Western Pharmacology Society 45 (2002) 199-210
110. Vink G.J., and Moodley J. The effect of low-dose dihydralazine on the fetus in the emergency treatment of hypertension in pregnancy. South African Medical Journal 62 (1982) 475-477
111. Visser W., and Wallenburg H.C. Central hemodynamic observations in untreated preeclamptic patients. Hypertension 17 (1991) 1072-1077
112. Visser W.H., Burggraaf J., Muller L.M., Schoemaker R., Fowler P., Cohen A.F., and Ferrari M.D. Pharmacokinetic and pharmacodynamic profiles of sumatriptan in migraine patients with headache recurrence or no response. Clinical Pharmacology and Therapeutics 60 (1996) 452-460
113. Visser W.H., de Vriend R.H.M., Jaspers N.M.W.H., and Ferrari M.D. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 47 (1996) 46-51
114. Visser W.H., Jaspers N.M.W.H., de Vriend R.H.M., and Ferrari M.D. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Cephalalgia 16 (1996) 554-559
115. Vrints C.J., Bult H., Bosmans J., Herman A.G., and Snoeck J.P. Paradoxical vasoconstriction as result of acetylcholine and serotonin in diseased human coronary arteries. European Heart Journal 13 (1992) 824-831
116. Wackenfors A., Jarvius M., Ingemansson R., Edvinsson L., and Malmsjo M. Triptans induce vasoconstriction of human arteries and veins from the thoracic wall. Journal of Cardiovascular Pharmacology 45 (2005) 476-484
117. Wallenburg H.C., and Visser W. Pregnancy-induced hypertensive disorders. Current Opinion in Obstetrics & Gynecology 6 (1994) 19-29
118. 1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats. Acta Pharmacologica Sinica 22 (2001) 269-273
119. Wasson S., and Jayam V.K. Coronary vasospasm and myocardial infarction induced by oral sumatriptan. Clinical Neuropharmacology 27 (2004) 198-200
120. Weiner C.P. The role of serotonin in the genesis of hypertension in preeclampsia. American Journal of Obstetrics and Gynecology 156 (1987) 885-888
121. Weir R.A., Oldroyd K.G., and Walters M.R. Myocardial infarction after oral sumatriptan use in a woman with normal coronary arteries. The American Journal of Medicine 120 (2007) e7-e8
122. Wimalasundera R.C., Thom S.A., Regan L., and Hughes A.D. Effects of vasoactive agents on intracellular calcium and force in myometrial and subcutaneous resistance arteries isolated from preeclamptic, pregnant, and nonpregnant woman. American Journal of Obstetrics and Gynecology 192 (2005) 625-632
123. Winbury M.M., and Howe B.B. Stenosis: regional myocardial ischemia and reserve. In: Winbury M.M., and Abiko Y. (Eds). Ischaemic Myocardium and Antianginal Drugs (1979), Raven Press, New York 55-76
124. Woisetschlager C., Waldenhofer U., Bur A., Herkner H., Kiss H., Binder M., Laggner A.N., and Hirschl M.M. Increased blood pressure response to the cold pressor test in pregnant women developing pre-eclampsia. Journal of Hypertension 18 (2000) 399-403
125. Yang Z.H., Richard V., von Segesser L., Bauer E., Stulz P., Turina M., and Luscher T.F. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm?. Circulation 82 (1990) 188-195
126. Yildiz O., and Tuncer M. Amplification of responses to sumatriptan by various agonists in rabbit isolated iliac artery. Journal of Cardiovascular Pharmacology 25 (1995) 508-510
127. 1-like receptor-mediated contraction in the human internal mammary artery. Journal of Cardiovascular Pharmacology 28 (1996) 6-10